This bill creates the first federal framework for regulating cannabinoid products—things like CBD oils, hemp-derived products, and other cannabis-related items sold to consumers. Right now, these products exist in a legal gray area, but this law would bring them under FDA oversight similar to how the agency regulates food and drugs.

Here's what the bill does in practical terms: Any company making or selling cannabinoid products would need to register with the FDA and follow strict manufacturing standards. Products would need clear labeling showing exactly what's in them, how much THC (the ingredient that gets you high) is present, and warnings about potential risks—especially for children, pregnant women, and people taking medications. The bill bans products designed to appeal to kids, like gummy bears shaped like cartoon characters. Companies would also have to test their products in certified labs to make sure they're not contaminated with pesticides, heavy metals, or other harmful substances.

The law sets an age limit of 21 for buying cannabinoid products with detectable THC levels, and it requires age verification for online sales. States can still set their own rules about how much THC is allowed in products sold within their borders. The FDA would have power to inspect facilities, pull dangerous products off shelves, and suspend registrations if companies aren't following the rules. Basically, this bill treats cannabinoid products more like regulated consumer goods rather than the largely unregulated products they are today, aiming to protect people from contaminated or mislabeled products while giving states flexibility in how strict they want to be.